Drug Discovery World
NOVEMBER 8, 2023
Sebastian Jaeger, PhD, Senior Scientist, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA, on: ‘Evaluation of Fcab-drug conjugates as a novel antibody-based format for targeted drug delivery’.
Drug Discovery World
NOVEMBER 17, 2022
Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery. . The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape.
Drug Discovery World
NOVEMBER 9, 2023
Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’. Engineering for higher avidity and multi-valency Following chairperson’s remarks from Bruce Keyt, PhD, CSO, R&D, IGM Biosciences, there will be three presentations in this session.
Expert insights. Personalized for you.
64 
Let's personalize your content